Sagimet Biosciences Inc.
SGMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001400118
In the last 90 days, Sagimet Biosciences Inc. insiders filed 0 open-market purchases and 5 sales; 122 institutions reported holding it in 13F filings for Q2 2026, worth $394.3M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Superinvestors holding SGMT, Q2 2026
1 superinvestor reports holding Sagimet Biosciences Inc. on Form 13F, worth $5.60M in total. Weight is Sagimet Biosciences Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| HHLR Advisors (Hillhouse)Zhang Lei | 0.7% | 724,800 | $5.60M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SGMT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2024
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−50.0%)
Q3 2023
1 superinvestor holding at quarter end